Insights - Page 93 of 107 - LucidQuest Ventures

Hematology Weekly News - February 24th 2025

February 24, 2025clinical trials,precision medicine,cancer treatment,cancer research,BioPharma and Tech News,Leukemia,LymphomaMedical Breakthroughs,Hematology News

🔬 Latest Breakthroughs in Hematology: Mantle Cell Lymphoma, Leukemia Advances…

by LucidQuest

Hematology Weekly News - February 24th 2025

February 24, 2025precision medicine,BioPharma and Tech News,LeukemiaLymphoma,Hematology News

🔬 Latest Breakthroughs in Hematology: Mantle Cell Lymphoma, Leukemia Advances…

by LucidQuest

Oncology Weekly News - February 24th 2025

February 24, 2025clinical trials,cancer research,fda approval,immunotherapy,prostate cancer,BioPharma and Tech News,lung cancer,medical innovation,mRNA VaccinePancreatic cancer,Oncology News

🏥 Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Trials & More This…

by LucidQuest

ESGO 2025 Preview: Highlights in Gynecologic Oncology to Watch

February 20, 2025Our Insights,breast cancerhpv,Ovarian Cancer,endometrial cancer,cervical cancer,Conference Previews,ai in oncology,ESGO 2025,gynecologic oncology,personalized surgery,survivorship,uterine sarcoma,gestational trophoblastic tumors

ESGO 2025 at a Glance Get ready for ESGO 2025 in Rome. LucidQuest…

by LucidQuest

ECCO 2025 Preview: Key Crohn’s and Colitis Highlights to Watch

February 19, 2025Our Insights,digital healthUlcerative Colitis,Crohns Disease,Biomarkers,inflammatory bowel disease,Conference Previews,Microbiome analysis,Endoscopy AI,Histology AI

ECCO 2025 at a glance As ECCO 2025 approaches, LucidQuest summarizes the…

by Matina Laloumi

Obesity Weekly News - Feb 18th 2025

February 18, 2025BioPharma and Tech News,GLP-1Weight Loss Drugs,Obesity News

The Future of Obesity Treatments: Groundbreaking Innovations & Market…

by LucidQuest

Hematology Weekly News - February 17th 2025

February 17, 2025Multiple Myeloma,blood cancer,BioPharma and Tech News,CAR T,LeukemiaLymphoma,Hematology News

🔬 Hematology & Blood Cancer Updates: Weekly Clinical Research & FDA…

by LucidQuest

Oncology Weekly News - February 17th 2025

February 17, 2025clinical trials,cancer research,fda approval,immunotherapy,prostate cancer,BioPharma and Tech News,lung cancer,Colorectal Cancer,Ovarian Cancermedical innovation,Oncology News

🏥 Oncology Update: Cancer Trials, Immunotherapy, PADCEV & KEYTRUDA This…

by LucidQuest

Obesity Weekly News - Feb 12th 2025

February 12, 2025clinical trials,Amgen,fda approval,BioPharma and Tech News,obesity,Novo Nordisk,Eli LillyWeight Loss Drugs,Obesity News

Latest obesity treatment advancements: Clinical trial updates and…

by LucidQuest

Oncology Weekly News - February 10th 2025

February 10, 2025clinical trials,cancer research,fda approval,immunotherapy,prostate cancer,BioPharma and Tech News,lung cancer,Colorectal Cancer,Ovarian CancerLucid Quest,Oncology News

🏥 Oncology Advances: Radium-223, Pembrolizumab, Cabozantinib,…

by LucidQuest

Hematology Weekly News - February 10th 2025

February 10, 2025clinical trials,cancer research,fda approval,immunotherapy,BioPharma and Tech News,CAR T,medical innovation,Leukemia,LymphomaLucidQuest,Hematology News

Hematology Updates: Mim8, Breyanzi, Axi-Cel, Ziftomenib, CAR-T, DLBCL, MCL,…

by LucidQuest

IMCAS 2025 Preview: Key Aesthetic Medicine Highlights to Watch

January 30, 2025Our Insights,Conference Previewsacne,IMCAS 2025,aesthetic medicine,hair loss treatments,skin conditions,facial rejuvenation,lasers,energy devices,melasma,threads,AI in aesthetic medicine

IMCAS 2025 at a glance Prepare for IMCAS 2025 with LucidQuest’s preview,…

by LucidQuest

Minimize Uncertainty – Make Informed Decisions – Succeed